COVID-19 in children with haematological malignancies
Research output: Contribution to journal › Article
- Birmingham Children’s Hospital NHS Foundation Trust,
- University of Leeds
- Children's Cancer and Leukaemia Group
- University of Oxford
- National Cancer Registration and Analysis Service (NCRAS)
- University of Nottingham
- University of Manchester
- Public Health England
- Leeds Children's Hospital
- University of York
Children with cancer are not at increased risk of severe SARS-CoV-2 infection; however, adults with haematological malignancies have increased risk of severe infections compared with non-haematological malignancies.
We compared patients with haematological and non-haematological malignancies enrolled in the UK Paediatric Coronavirus Cancer Monitoring Project between 12 March 2020 and 16 February 2021. Children who received stem cell transplantation were excluded.
Only 2/62 patients with haematological malignancy had severe/critical infections, with an OR of 0.5 for patients with haematological compared with non-haematological malignancies.
Children with haematological malignancies are at no greater risk of severe SARS-CoV-2 infection than those with non-haematological malignancies.
Data availability statement
Data are available on reasonable request. The database contains de-identified participant data which are anonymised at source prior to upload. Reasonable requests for data sharing will be considered.
|Journal||Archives of Disease in Childhood|
|Early online date||22 Jul 2021|
|Publication status||E-pub ahead of print - 22 Jul 2021|